I-MAB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.56 EUR | -0.64% |
|
0.00% | -5.45% |
| 06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
| 06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
6286103ae94.it5HSujwpI4Wtx62VrgEIeGQEjQ87FThoh8rpjuN2Hw.wuwRB72i_elj51LBZckxVtDjfXoJphGjzClin2jDryjurCEcgZLn2HvgWw~1dd611af9ad6da91ded60e755ab2ba94
